Zhu, H., Fan, W., Zhao, C., Wang, S., Li, Y., Jin, Z., Zhang, Z., Guo, J., Cheng, H., Zhang, Q., Lu, J., Zeng, Y., Lv, W., Xu, H., Shao, H., Xu, W., Zhao, X., Gu, S., Lin, H., Zheng, W., Piao, L., Song, Y., Zhao, J., Wang, Y., Hou, Z., Sun, Y., Guan, N., Huang, M., Yang, W., Ji, J., Teng, G. (2026). Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-01796